Myosin Therapeutics Wins $4.5M Grant for Glioblastoma Trial
Myosin Therapeutics, a biotechnology company developing novel therapies for aggressive cancers, today announced it has been awarded a $4.5M Phase IIB Bridge Award from the National Cancer...